Clinical toxicity of synthetic cannabinoid receptor agonist use

被引：0
|
作者：
Manini, Alex F. [1 ]
Hoffman, Robert S. [2 ]
Stimmel, Barry [3 ]
Vlahov, David [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Med Toxicol, New York, NY 10029 USA
[2] NYU, Sch Med, Div Med Toxicol, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA
[4] UCSF Sch Nursing, Off Dean, San Francisco, CA USA
来源：
CLINICAL TOXICOLOGY | 2015年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
269
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [31] Internet availability of synthetic cannabinoid receptor agonists for use with electronic vaping devices
    Gould, Allon
    Dargan, Paul I.
    Wood, David M.
    [J]. CLINICAL TOXICOLOGY, 2024, 62 : 1 - 2
  • [32] Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis
    Parlar, Ali
    Arslan, Seyfullah Oktay
    Yumrutas, Onder
    Elibol, Ebru
    Yalcin, Alper
    Uckardes, Fatih
    Aydin, Hasan
    Dogan, Muhammed Fatih
    Kayhan Kustepe, Elif
    Ozer, Mehmet Kaya
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (01) : 48 - 59
  • [33] Cumyl-CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain
    Halter, Sebastian
    Pulver, Benedikt
    Wilde, Maurice
    Haschimi, Belal
    Westphal, Folker
    Riedel, Jan
    Puetz, Michael
    Schoenberger, Torsten
    Stoll, Stefanie
    Schaeper, Jan
    Auwaerter, Volker
    [J]. DRUG TESTING AND ANALYSIS, 2021, 13 (01) : 208 - 216
  • [34] Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?
    Halter, Sebastian
    Angerer, Verena
    Roehrich, Joerg
    Groth, Olwen
    Roider, Gabriele
    Hermanns-Clausen, Maren
    Auwaerter, Volker
    [J]. DRUG TESTING AND ANALYSIS, 2019, 11 (02) : 347 - 349
  • [35] Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo, Collin
    Mazer-Amirshahi, Maryann
    DeGeorge, Lindsey
    Gelfand, Bradley
    Leak, Chikarlo
    Tolliver, Samantha
    Sauter, Diane
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (10): : 1846 - 1849
  • [36] Cannabinoid receptor type 2 agonist JWH-133 deteriorates the liver toxicity induced by cypermethrin
    Tutun, Hidayet
    Baydan, Emine
    [J]. TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES, 2018, 42 (03): : 211 - 221
  • [37] SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE
    Lucas, Catherine
    Ezard, Nadine
    Day, Richard
    [J]. DRUG AND ALCOHOL REVIEW, 2013, 32 : 48 - 48
  • [38] CONVULSIONS AS A COMPLICATION OF SYNTHETIC CANNABINOID USE
    Schneir, Aaron
    Baumbacher, Todd
    [J]. CLINICAL TOXICOLOGY, 2011, 49 (06) : 526 - 526
  • [39] Patterns of synthetic cannabinoid use in Australia
    Barratt, Monica J.
    Cakic, Vince
    Lenton, Simon
    [J]. DRUG AND ALCOHOL REVIEW, 2013, 32 (02) : 141 - 146
  • [40] Synthetic Cannabinoid Use: Recognition and Management
    Castellanos, Daniel
    Thornton, Gabriel
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2012, 18 (02) : 86 - 93
12345